Abcam (ABCZY) Short Interest Ratio & Short Volume

Short interest is the volume of Abcam shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 1,900 shares of ABCZY short. Learn More on Abcam's current short interest.

Abcam saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 1,900 shares, a decline of 75.9% from the previous total of 7,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Abcam: Genmab A/S (0.11%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.33%), Dr. Reddy's Laboratories Limited (1.91%), Moderna, Inc. (16.48%), Ascendis Pharma A/S (11.37%), Viatris Inc. (3.96%), Qiagen (2.11%), Roivant Sciences Ltd. (11.68%), Revolution Medicines, Inc. (10.62%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.12 billion), Aon plc ($3.90 billion), The Clorox Company ($3.00 billion), Analog Devices, Inc. ($2.81 billion), The Kroger Co. ($2.31 billion), Moderna, Inc. ($2.09 billion), Datadog, Inc. ($2.05 billion), Peloton Interactive, Inc. ($2.02 billion), Uber Technologies, Inc. ($1.99 billion), and International Flavors & Fragrances Inc. ($1.85 billion). View all of the most shorted stocks.

Short selling ABCZY is an investing strategy that aims to generate trading profit from Abcam as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Abcam occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABCZY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABCZY, twice per month. The most recent reporting period available is October, 15 2020.